Scarica l'app Stockscreener
43.84
2.01%
-0.90
Dopo l'orario di chiusura:
43.84
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché INSP Giù?
Forum
Previsione
Precedente Chiudi:
$44.74
Aprire:
$42.89
Volume 24 ore:
1.38M
Relative Volume:
1.19
Capitalizzazione di mercato:
$1.26B
Reddito:
$915.25M
Utile/perdita netta:
$131.14M
Rapporto P/E:
9.8032
EPS:
4.472
Flusso di cassa netto:
$96.71M
1 W Prestazione:
+9.46%
1M Prestazione:
-19.11%
6M Prestazione:
-51.22%
1 anno Prestazione:
-69.96%
Intervallo 1D:
$42.60
$44.26
Intervallo di 1 settimana:
$40.37
$44.98
Portata 52W:
$39.61
$147.66
Inspire Medical Systems Inc Stock (INSP) Company Profile
Nome
Inspire Medical Systems Inc
Settore
Industria
Telefono
763-957-5037
Indirizzo
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
43.84 | 1.29B | 915.25M | 131.14M | 96.71M | 4.472 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-13 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2026-02-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2026-02-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2026-01-27 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2026-01-22 | Downgrade | Truist | Buy → Hold |
| 2025-12-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Aggiornamento | Truist | Hold → Buy |
| 2025-11-25 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Aggiornamento | Stifel | Hold → Buy |
| 2025-11-04 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | Downgrade | Jefferies | Buy → Hold |
| 2025-09-22 | Downgrade | UBS | Buy → Neutral |
| 2025-09-02 | Iniziato | Evercore ISI | Outperform |
| 2025-08-05 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-08-05 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | Downgrade | Truist | Buy → Hold |
| 2024-11-20 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-05-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-04-19 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-03-19 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Iniziato | Jefferies | Buy |
| 2024-01-02 | Downgrade | Stifel | Buy → Hold |
| 2023-12-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-04-14 | Iniziato | Mizuho | Buy |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-12-13 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-01-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-12-15 | Downgrade | Goldman | Buy → Neutral |
| 2020-11-03 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-11-03 | Aggiornamento | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Iniziato | JP Morgan | Overweight |
| 2020-09-02 | Iniziato | Robert W. Baird | Outperform |
| 2020-08-06 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-07-15 | Iniziato | Goldman | Buy |
| 2020-06-18 | Reiterato | Piper Sandler | Overweight |
| 2020-05-18 | Iniziato | Lake Street | Buy |
| 2020-04-28 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Iniziato | Piper Sandler | Overweight |
| 2020-01-28 | Iniziato | Oppenheimer | Underperform |
| 2020-01-27 | Iniziato | Oppenheimer | Underperform |
| 2019-11-06 | Aggiornamento | Berenberg | Sell → Hold |
| 2019-02-05 | Iniziato | Dougherty & Company | Buy |
| 2018-11-28 | Iniziato | Berenberg | Sell |
| 2018-10-29 | Iniziato | Leerink Partners | Outperform |
| 2018-05-29 | Iniziato | Guggenheim | Buy |
| 2018-05-29 | Iniziato | Stifel | Buy |
| 2018-05-29 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Inspire Medical Systems Inc Borsa (INSP) Ultime notizie
Inspire Medical Systems (INSP) Cuts 2026 Outlook Amid Medicare Uncertainty and Insider Sale – What’s Changed? - Sahm
(INSP) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Inspire Medical drops as BofA cuts to underperform on lack of coding clarity - MSN
BofA Securities Downgrades Inspire Medical Systems(INSP.US) to Sell Rating, Cuts Target Price to $39 - Moomoo
Inspire Medical Systems (INSP) price target decreased by 17.14% to 72.73 - MSN
BofA analysts downgrade Inspire Medical on reimbursement coding concerns - MassDevice
Inspire Medical Systems, Inc. Stock 12‑Month Price Target Cut to $52, Implies 16% Upside - TradingView
Inspire Medical Systems Faces Coding Overhang, Estimate Risks, BofA Says - Moomoo
Why is Inspire Medical stock sliding today? By Investing.com - Investing.com Canada
Inspire Medical stock cut to Underperform at BofA (INSP:NYSE) - Seeking Alpha
BofA downgrades Inspire Medical stock rating on coding concerns - Investing.com
BofA downgrades Inspire Medical stock rating on coding concerns By Investing.com - Investing.com Canada
BofA Securities Downgrades Inspire Medical Systems to Underperform From Neutral, Price Target is $39 - marketscreener.com
Inspire Medical Systems (INSP) Stock Forecast and Price Target 2026 $INSP - MarketBeat
Device to Prevent Airway Collapse During Sleep is Released in the U.K. - Medical Product Outsourcing
Insider Sell Alert: John Rondoni Sells Shares of Inspire Medical Systems Inc (INSP) - GuruFocus
Officer at Inspire Medical (NYSE: INSP) sells 2,641 shares - Stock Titan
Inspire Medical Systems, Inc. (INSP): Investor Outlook Highlights 33% Potential Upside - DirectorsTalk Interviews
INSP Technical Analysis | Trend, Signals & Chart Patterns | INSPIRE MEDICAL SYSTEMS INC (NYSE:INSP) - ChartMill
Inspire Medical Systems (INSP) Is Down 9.5% After Cutting 2026 Outlook And Filing ESOP Shelf RegistrationWhat's Changed - Sahm
Insider Sell Alert: John Rondoni Sells 700 Shares of Inspire Med - GuruFocus
[144] Inspire Medical Systems, Inc. SEC Filing - Stock Titan
Inspire Medical (INSP) officer sells 700 shares at about $43 - Stock Titan
Wellington Group reports 2.54M Inspire shares (INSP) representing 8.81% stake - Stock Titan
[SCHEDULE 13G/A] Inspire Medical Systems, Inc. Amended Passive Investment Disclosure - Stock Titan
INSP (NYSE) Form 144: Director/Holder Notices Sale of 700 Shares via Morgan Stanley - Stock Titan
How (INSP) Movements Inform Risk Allocation Models - Stock Traders Daily
Transcript : Inspire Medical Systems, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 08 - marketscreener.com
5 Insightful Analyst Questions From Inspire Medical Systems’s Q1 Earnings Call - Yahoo Finance
What Does The Future Hold For Inspire Medical Systems, Inc. (NYSE:INSP)? These Analysts Have Been Cutting Their Estimates - 富途牛牛
Inspire Medical Systems stock hits 52-week low at $43.01 By Investing.com - Investing.com South Africa
A Look At Inspire Medical Systems (INSP) Valuation After Forecast Downgrades And Guidance Reset - Sahm
Inspire Medical Systems stock hits 52-week low at $43.01 - Investing.com
Inspire Medical Systems director Shawn McCormick sells $31,535 stock - Investing.com UK
Inspire Medical Systems director Shawn McCormick sells $31,535 stock By Investing.com - Investing.com South Africa
Director at Inspire Medical (NYSE: INSP) sells 696 company shares - Stock Titan
Investors Shouldn't Be Too Comfortable With Inspire Medical Systems' (NYSE:INSP) Earnings - Moomoo
Things Look Grim For Inspire Medical Systems, Inc. (NYSE:INSP) After Today's Downgrade - Yahoo Finance
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Is a 20.50% Potential Upside Worth the Investment? - DirectorsTalk Interviews
Inspire Medical Systems (INSP) Is Down 18.8% After Cutting 2026 Outlook And Filing Share Offering – Has The Bull Case Changed? - Sahm
Inspire Medical Systems (INSP) Is Down 18.8% After Cutting 2026 Guidance Amid Reimbursement ChallengesWhat's Changed - Yahoo Finance
Inspire Medical Systems, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:INSP) 2026-05-08 - Seeking Alpha
INSP SEC FilingsInspire Medical 10-K, 10-Q, 8-K Forms - Stock Titan
INSP Maintained by Oppenheimer -- Rating Remains at Perform - GuruFocus
Inspire Medical Systems (NYSE:INSP) Receives Market Perform Rating from Oppenheimer - MarketBeat
Inspire Medical Systems Inc (INSP) Stock News & Articles - 24/7 Wall St.
symbol__ Stock Quote Price and Forecast - CNN
Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Cuts Target Price to $56 - Moomoo
Inspire Medical Systems Inc Azioni (INSP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.22%
1.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):